The 10 VCs betting the most on turning MDMA and magic mushrooms into medicines
Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- We found the 10 top psychedelic VCs;
- Delta is hitting heavily Republican states hardest;
- The US is lagging other countries in sequencing COVID-19 tests.
If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...
Meet the top 10 VCs who've bet the most cash on turning MDMA and magic mushrooms into medicines
- Insider tracked down the top 10 VCs in the psychedelics space.
- We asked each firm how many deals they've made and how much they've deployed into the industry.
- The 10 firms on this list have invested about $79 million altogether.
The Delta variant is hitting red states hardest as the US's vaccine divide widens
- The Delta variant is sickening people most in unvaccinated, heavily Republican states.
- Arkansas, Mississippi, Missouri, and Wyoming have seen upticks in cases and hospitalizations.
- But the variant has had little effect in blue states such as Maine, New Hampshire, and Vermont.
The US doesn't really know how widespread the Delta variant is because its virus sequencing is lagging far behind many other rich nations
- The US doesn't really know how widespread Delta is because of inadequate sequencing of tests.
- In the past six months, just 4% of all positive COVID-19 were sequenced and reported to a central database.
- The UK is at 18.6%, Singapore 46.5%, Australia 58.7%, and New Zealand 41.5%.
More stories we're reading:
- Data from Fitbit suggests people with COVID-19 had lingering impacts to their overall health (MobiHealth News)
- Olivia Rodrigo will visit the White House to record pro-vaccination videos with Fauci (Insider)
- Tennessee is stopping all adolescent vaccine outreach (The Tennessean)
- A health startup founder who raised $40 million plans to improve healthcare access in the US (Business Insider Spain)
- Lydia